U.S. Paper and Forestry Products Stock News

NYSE:GPK
NYSE:GPKPackaging

Graphic Packaging Holding (GPK) Margin Compression Challenges Bullish Earnings Growth Narratives

Graphic Packaging Holding (GPK) has just posted its FY 2025 third quarter numbers, with revenue of about US$2.2 billion, basic EPS of US$0.48 and net income of US$142 million, while trailing 12 month figures show revenue of US$8.6 billion, EPS of US$1.70 and net income of US$511 million. Over the past few quarters, revenue has moved in a tight band from US$2.09 billion in Q4 2024 to between US$2.12 billion and US$2.20 billion through 2025, while quarterly EPS has ranged from US$0.35 to...
NYSE:GWW
NYSE:GWWTrade Distributors

Grainger (GWW) Margin Compression Reinforces Bearish Narrative Despite Solid Revenue Base

W.W. Grainger (GWW) opened FY 2025 with third quarter revenue of US$4.7b and basic EPS of US$6.15, set against a trailing twelve month line of US$17.8b in revenue and EPS of US$35.93. The company has seen quarterly revenue move from US$4.31b in Q2 2024 to US$4.55b in Q2 2025, and from US$4.39b in Q3 2024 to US$4.66b in Q3 2025, while basic EPS has ranged from roughly US$9.59 to US$10.04 across those prior quarters. With a net margin that has eased from 10.8% to 9.7% over the last year, this...
NYSE:CALX
NYSE:CALXCommunications

A Look At Calix (CALX) Valuation After Record Earnings Cloud Progress And Expanded Buybacks

Why Calix’s latest earnings are drawing fresh attention Calix (CALX) is back in focus after reporting record quarterly and full year results, highlighting higher revenue and a swing to profit, while advancing its cloud platform transition and expanding its share repurchase authorization. The company reported fourth quarter revenue of US$272.45 million, with net income of US$7.21 million, compared with a net loss in the same period a year earlier. For 2025 as a whole, revenue was US$1.00...
NYSE:AMR
NYSE:AMRMetals and Mining

Is Alpha’s Rare Quarterly Loss and Ongoing Buybacks Altering The Investment Case For Alpha Metallurgical Resources (AMR)?

Alpha Metallurgical Resources recently issued preliminary unaudited guidance indicating it expects to report a net loss of US$17.3 million, or US$1.34 per diluted share, for the fourth quarter of 2025, and confirmed it has repurchased 113,000 shares for US$20 million in the final quarter of 2025. This update highlights a rare quarterly loss for a company that has emphasized conservative capital allocation and has retired over 43% of its shares since March 2022. We’ll examine how the...
NYSE:OWL
NYSE:OWLCapital Markets

Blue Owl Capital (OWL) Is Down 16.7% After Liquidity, Legal And AI-Exposure Concerns Intensify

In recent months, Blue Owl Capital has been hit by securities fraud class action claims, a federal lawsuit over a “quiet” US$150,000,000 withdrawal from a private credit fund, and rising concerns about liquidity and redemption limits for retail investors. At the same time, alongside broader worries that artificial intelligence could undercut software-focused portfolios, these legal and operational pressures have sharpened investor focus on Blue Owl’s risk profile and business model...
NasdaqGS:OMCL
NasdaqGS:OMCLMedical Equipment

Is Omnicell (OMCL) Starting To Look Interesting After Recent Share Price Swings?

If you are wondering whether Omnicell at around US$46 is a bargain or a value trap, this article will walk you through what the current price might be implying. The stock has had a mixed run, with a 7.8% decline over the last week, a 2.0% gain over the past month, and returns of 2.0% year to date and 5.0% over the last year. It is still sitting well below its 3 year and 5 year levels, with declines of 21.0% and 65.2% over those periods. Recent coverage around Omnicell has focused on its role...
NYSE:ALL
NYSE:ALLInsurance

Allstate (ALL) Valuation Check After Mixed Returns And Discount To Estimated Fair Value

What Allstate’s Latest Figures Tell Investors Allstate (ALL) is back in focus as investors reassess the insurer’s recent share performance and financial profile, with the stock last closing at $201.77 and showing mixed returns across different time frames. Over the past week, the share price return was about 3.6%, while the month return was a decline of roughly 1%. Over the past 3 months, the stock shows a gain of about 3.6%, and the 1 year total return is close to 7.8%. Looking at a longer...
NYSE:BLDR
NYSE:BLDRBuilding

Is Builders FirstSource (BLDR) Still Attractive After A Mixed Year Of Share Price Moves

If you are wondering whether Builders FirstSource at around US$118 still offers solid value, or if most of the opportunity is already priced in, this article is designed to help you assess that for yourself. The stock has a 7 day return of 1.1%, a 30 day and year to date return of 13.3%, but a 1 year return showing a 27.5% decline, so recent moves look very different depending on the time frame you focus on. Recent market attention has been shaped by ongoing interest in US housing and...
NYSE:BEN
NYSE:BENCapital Markets

Franklin Resources (BEN) Valuation Check After Strong Earnings Beat And Growing ETF And Alternatives Businesses

Franklin Resources (BEN) is back in focus after reporting first quarter 2026 earnings that topped Wall Street expectations, supported by strong long term net inflows, growth in alternatives, and record ETF assets under management. See our latest analysis for Franklin Resources. The earnings beat, ongoing buybacks and the launch of the AI powered Intelligence Hub with Microsoft arrive as the shares trade at US$27.0, with a 30 day share price return of 13.45% and a 1 year total shareholder...
NYSE:MAS
NYSE:MASBuilding

A Look At Masco (MAS) Valuation After A Weak Q3 And Challenging Market Commentary

Q3 earnings miss and market reaction Masco (MAS) reported a disappointing Q3, with revenue down 3.3% year on year and adjusted operating income and EBITDA below analyst expectations, with management pointing to challenging market conditions as a key headwind. See our latest analysis for Masco. Despite the weak Q3, Masco’s share price has shown positive short term momentum, with a 30 day share price return of 5.55% and a 3 year total shareholder return of 31.90%, although the 1 year total...
NYSE:RITM
NYSE:RITMMortgage REITs

Rithm Capital (RITM) TTM Earnings Surge 60.5% Tests Bearish Cash Flow Narratives

Rithm Capital (RITM) has put up a steady run of numbers heading into FY 2025, with third quarter revenue at US$943 million and basic EPS of US$0.36, alongside trailing twelve month revenue of about US$4.0 billion and EPS of US$1.47. The company has seen quarterly revenue move between US$646 million and US$1.3 billion over the last six reported periods, with basic EPS ranging from US$0.07 to US$0.54. This sets a clear backdrop for how investors might read the current US$10.95 share price...
NasdaqGS:AVGO
NasdaqGS:AVGOSemiconductor

Is It Too Late To Consider Broadcom (AVGO) After A 7x Five Year Run?

Some investors may be wondering if Broadcom's share price still offers value after a large multi year run, or if most of the upside is already reflected in the stock. The shares closed at US$320.33, with a 3.7% decline over the last 7 days and a 7.9% decline over the last 30 days. Over the last 1 year the return sits at 45.3%, and the 5 year return is around 7x. Recent news coverage has focused on Broadcom's role as a major semiconductor and infrastructure software player and how that...
NYSE:RES
NYSE:RESEnergy Services

RPC (RES) Margin Compression Challenges Bullish Narratives Despite FY 2025 Q3 Revenue Scale

RPC (RES) has just posted its FY 2025 third quarter scorecard, reporting revenue of $447.1 million and basic EPS of $0.06. This puts fresh numbers on the table after a run of mixed earnings over the past year. The company’s revenue has moved from $364.2 million in FY 2024 Q2 to $337.7 million in Q3 and $335.4 million in Q4, then to $332.9 million, $420.8 million and now $447.1 million through FY 2025. Over the same stretch, quarterly EPS shifted from $0.15 to $0.09, $0.06, $0.06, $0.05 and...
NYSE:SR
NYSE:SRGas Utilities

How Investors Are Reacting To Spire (SR) Redeeming Preferred Shares And Reaffirming Dividend And Guidance

Spire Inc. reported past first‑quarter 2026 results with sales of US$762.2 million and net income of US$95 million, alongside announcing the redemption of all 5.90% Series A preferred shares and affirming its quarterly common dividend of US$0.825 per share. Beyond the headline earnings growth, Spire’s decision to retire its higher-cost preferred stock while pursuing an US$11.2 billion long-term capital plan underpins a clearer, streamlined capital structure and reinforces management’s focus...
NYSE:WAT
NYSE:WATLife Sciences

Waters Reshapes Growth Path With Wyatt Deal And BD Biosciences Merger

Waters Corporation (NYSE:WAT) has completed its acquisition of Wyatt Technology as part of a broader shift in its business strategy. The company has also announced a planned merger with BD Biosciences, signaling a push deeper into large molecule applications. These moves are expected to reshape Waters' role in the biotech and life sciences tools space, with implications for its future operations. Waters, trading at $378.95, is responding to a period of mixed share performance with an active...
NYSE:DT
NYSE:DTSoftware

Can Dynatrace (DT) Turning Its Platform Into An AI Control Plane Reshape Its Competitive Moat?

At its Perform 2026 user conference held in late January, Dynatrace unveiled Dynatrace Intelligence, fusing deterministic and agentic AI, alongside expanded multi-cloud integrations and next-generation real user monitoring capabilities. An interesting aspect of these launches is Dynatrace’s push to position its platform as a control plane for AI in production, aiming to automate complex IT and business operations. We’ll now examine how Dynatrace Intelligence’s focus on agentic AI and...
NasdaqGS:NWL
NasdaqGS:NWLConsumer Durables

Is Newell Brands (NWL) Still Mispriced After Recent Share Price Rebound?

If you are wondering whether Newell Brands' current share price reflects its true worth, you are not alone. This article walks through what the latest data says about value. The stock most recently closed at US$4.40, with returns of 0.9% over 7 days and 18.3% over both the last 30 days and year to date, against a longer term record that includes a 52.0% decline over 1 year, 67.4% over 3 years and 79.4% over 5 years. Those mixed returns sit against a backdrop of ongoing attention on Newell...
NasdaqGS:TWST
NasdaqGS:TWSTBiotechs

Twist Bioscience Raises Outlook As AI DNA Demand Builds Profit Focus

Twist Bioscience (NasdaqGS:TWST) reported its twelfth consecutive quarter of revenue growth. The company raised its full year outlook, citing momentum in AI enabled DNA synthesis and wider use of its platform. Management also reiterated a focus on progressing toward profitability alongside scaling the business. Twist Bioscience, a provider of synthetic DNA and related tools, operates at the intersection of biotechnology and AI driven research. Its platform supports customers in areas such...
NYSE:GEV
NYSE:GEVElectrical

GE Vernova Deepens Xcel Ties As Grid Offerings Broaden For Investors

GE Vernova (NYSE:GEV) has entered a wide-ranging alliance with Xcel Energy covering gas and wind turbine deployments, grid projects, and joint R&D in areas such as artificial intelligence. The company launched its GridBeats APS grid modernization platform, aimed at improving efficiency, resilience, and capacity across power networks. GE Vernova also completed the full acquisition of Prolec GE, integrating additional grid equipment capabilities into its portfolio. For you as an investor...
NYSE:GKOS
NYSE:GKOSMedical Equipment

How FDA Approval of Repeat iDose TR Use Will Impact Glaukos (GKOS) Investors

In late January 2026, Glaukos Corporation received FDA approval for an NDA labeling supplement that permits repeat administration of its long-duration iDose TR glaucoma implant, supported by clinical data showing safe and well-tolerated second treatments over 12 months. This decision effectively positions iDose TR as a potentially longer-term, repeatable treatment option aimed at reducing non-compliance and side effects linked to traditional eye-drop therapies for glaucoma. Next, we will...
NYSE:LION
NYSE:LIONEntertainment

Assessing Lionsgate Studios (LION) Valuation After Recent Share Price Volatility

Why Lionsgate Studios Stock Is Drawing Attention Now Lionsgate Studios (LION) has caught investor attention after recent trading left the share price at US$8.98, with returns ranging from a 3.4% decline over the month to a 33.2% gain in the past 3 months. See our latest analysis for Lionsgate Studios. Recent trading has been choppy, with a 1-day share price return of 2.7% decline and a 7-day share price return of 6.2% decline. However, the 90-day share price return of 33.2% suggests momentum...
NasdaqGS:EWBC
NasdaqGS:EWBCBanks

East West Bancorp Dividend Hike Highlights Earnings Strength And Payout Capacity

East West Bancorp (NasdaqGS:EWBC) announced a 33% increase in its quarterly dividend. The higher dividend follows the company’s latest annual and quarterly results, which management described as strong. The move signals an increased cash return to shareholders through the regular dividend. East West Bancorp is a commercially focused bank with a footprint that connects U.S. and Asia linked clients, serving businesses and individuals across a range of lending and deposit services. For...
NYSE:APH
NYSE:APHElectronic

Amphenol Expands Fiber Reach With CommScope Deal As AI Demand Builds

Amphenol (NYSE:APH) has agreed to acquire CommScope's Connectivity and Cable Solutions division, expanding its fiber optic interconnect offering. The move broadens Amphenol's presence in connectivity for AI data centers and communications infrastructure. The acquisition highlights management's focus on building out capabilities in high demand data and AI related applications. For investors watching NYSE:APH, this deal comes with the stock recently trading at $147.06 and showing very large 3...
NasdaqGS:CRVL
NasdaqGS:CRVLHealthcare

CorVel (CRVL) Earnings Growth And 11.3% Margin Challenge Cautious Narratives

CorVel (CRVL) has just wrapped up Q3 2026 with its recent numbers anchored by the latest reported quarter, where revenue in Q2 2026 was US$239.6 million and basic EPS came in at US$0.54. This feeds into trailing 12 month EPS of US$2.05 and net income of US$105.3 million. Over the recent reporting periods, the company has seen revenue move from US$224.4 million in Q2 2025 to US$239.6 million in Q2 2026, with basic EPS stepping from US$0.46 to US$0.54 over the same quarters. This sets up a...